Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287841 · ClinicalTrials.gov registry record · NA
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
A NA study of Allergic Rhinitis and Nasal Polyps, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 3
- Study locations
NCT05287841: Recruiting NA study of Allergic Rhinitis and Nasal Polyps, sponsored by Northwell Health.
NCT05287841 is a NA study of Allergic Rhinitis and Nasal Polyps that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 96 participants, roughly in line with the 101-participant average among 23 other Allergic Rhinitis trials with a reported enrollment target. The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287841, a NA study of Allergic Rhinitis and Nasal Polyps, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of this study is to compare the effectiveness of batten grafts plus septoplasty and turbinate reduction (intervention arm) compared to septoplasty and turbinate reduction alone (control arm), both in terms of subjective and objective assessments.
Primary Outcome
1. The NOSE scale is a scoring scale from 0 to 4 (0 = no problem for quality of life, 4 = a severe problem) under 5 different parameters 2. The sum of 5 different parameters are added up to give a range of possible sums from 0-20. This sum is then multiplied by 5 to give a final score with range 0-100. Ref: Stewart MG, Witsell DL, Smith TL, Weaver EM, Yueh B, Hannley MT. Development and validation of the nasal obstruction symptom evaluation (NOSE) scale. Otolaryngol Head Neck Surg 2004;130:157-
Conditions Studied
Interventions
- PROCEDURE Batten batten graft
- PROCEDURE Septoplasty
- PROCEDURE Inferior Turbinate Reduction
Study Locations (3)
New York
- Lenox Hill Hospital/Staten Island University Hospital - New York
- Staten Island University Hospital - Staten Island
Missouri
- Poplar Bluff Regional Medical Center - Poplar Bluff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2021-04-30 |
| Est. Completion | 2025-06-15 |
| Phase | NA |
What NCT05287841 shows while recruiting
NCT05287841 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, roughly in line with the 101-participant average among 23 other Allergic Rhinitis trials with a reported enrollment target.
The record links to 5 conditions, with Allergic Rhinitis appearing as the primary indexed condition, and to 3 interventions - of which Batten batten graft is the first listed.
NCT05287841 reports a single indexed study location in New York, Missouri.
Frequently Asked Questions
What is clinical trial NCT05287841 about?
NCT05287841 is a clinical study titled "Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?". The objective of this study is to compare the effectiveness of batten grafts plus septoplasty and turbinate reduction (intervention arm) compared to septoplasty and turbinate reduction alone (control arm), both in terms of subjective and objective assessments.
What is the current status of trial NCT05287841?
This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2021-04-30. Estimated completion is 2025-06-15.
What conditions does trial NCT05287841 study?
This clinical trial studies the following conditions: Allergic Rhinitis, Nasal Polyps, Nasal Obstruction, Nasal Valve Collapse, Septal Defect.
What interventions are being tested in trial NCT05287841?
The interventions under investigation include: Batten batten graft (PROCEDURE), Septoplasty (PROCEDURE), Inferior Turbinate Reduction (PROCEDURE).
Who is sponsoring clinical trial NCT05287841?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287841 being conducted?
This trial has 3 study locations across Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allergic Rhinitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05287841's enrollment target sits among peer trials
96 8th of 23 higher than 16 of 23 other Allergic Rhinitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Allergic Rhinitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Omalizumab on Responses to Cat Allergen Challenge
COMPLETED · NA
-
Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies
COMPLETED · NA
-
Viral Mucosal Reprogramming
RECRUITING · Phase 2
-
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
ACTIVE NOT RECRUITING · Phase 4
-
Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis
COMPLETED · Phase 3
-
Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI